One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?.
doi : 10.1200/JCO-24-02483
Volume 43(9) pgs. 1047-1172 March 20, 2025
What Is the Optimal Locoregional Approach for Recurrent Hepatocellular Carcinoma?.
doi : 10.1200/JCO-24-02541
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
doi : 10.1200/JCO.24.01121
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma.
doi : 10.1200/JCO-24-02242
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial.
doi : 10.1200/JCO-24-01532
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.
doi : 10.1200/JCO-24-01326
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.
doi : 10.1200/JCO-24-02086
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).
doi : 10.1200/JCO-24-01214
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT.
doi : 10.1200/JCO-24-01308
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.
doi : 10.1200/JCO-24-02138
De-Escalation Strategies With Immune Checkpoint Blockers in Non-Small Cell Lung Cancer: Do We Already Have Enough Evidence?.
doi : 10.1200/JCO-24-02347
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.
doi : 10.1200/JCO.24.01154
Expanding the Horizon of MRONJ Research in Breast Cancer Bone Metastasis Treatments.
doi : 10.1200/JCO-24-02205
Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Addressing Statistical and Methodological Concerns in Survival Analysis.
doi : 10.1200/JCO-24-02054
Reply to: Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Addressing Statistical and Methodological Concerns in Survival Analysis.
doi : 10.1200/JCO-24-02598
